19 Matching Annotations
  1. Jun 2026
  2. www.sciencedirect.com www.sciencedirect.com
    Pathogenesis of diffuse large B cell lymphoma proteogenotypes
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S1535610826002539
  3. Aug 2025
  4. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Blocking NRF2 Translation by Inhibition of Cap-Dependent Initiation Sensitizes Lymphoma Cells to Ferroptosis and CAR T-cell Immunotherapy
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC12363560/
  5. Feb 2025
  6. aacrjournals.org aacrjournals.org
    Repurposing NAMPT inhibitors for germinal center B-cell-like diffuse large B-cell lymphoma
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    aacrjournals.org/bloodcancerdiscov/article/5/6/417/749227/Repurposing-NAMPT-Inhibitors-for-Germinal-Center-B
  7. Sep 2024
  8. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Bifunctional inhibitor reveals NEK2 as a therapeutic target and regulator of oncogenic pathways in lymphoma
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC10932871/
  9. Jul 2024
  10. www.sciencedirect.com www.sciencedirect.com
    IRF4 requires ARID1A to establish plasma cell identity in multiple myeloma
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S1535610824002174
  11. May 2024
  12. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Novel Spirocyclic Dimer, SpiD3, Targets Chronic Lymphocytic Leukemia Survival Pathways with Potent Preclinical Effects
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC11110724/
  13. www.sciencedirect.com www.sciencedirect.com
    Molecular targets of glucocorticoids that elucidate their therapeutic efficacy in aggressive lymphomas
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S1535610824001314
  14. Apr 2024
  15. www.sciencedirect.com www.sciencedirect.com
    Functional genomics identifies N-acetyllactosamine extension of complex N-glycans as a mechanism to evade lysis by natural killer cells
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2211124724004339
  16. Mar 2024
  17. www.sciencedirect.com www.sciencedirect.com
    ARID1A orchestrates SWI/SNF-mediated sequential binding of transcription factors with ARID1A loss driving pre-memory B cell fate and lymphomagenesis
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S1535610824000540
  18. Feb 2024
  19. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Targeting N-linked Glycosylation for the Therapy of Aggressive Lymphomas
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC10524254/
  20. Jan 2024
  21. www.sciencedirect.com www.sciencedirect.com
    Response to Bruton’s tyrosine kinase inhibitors in aggressive lymphomas linked to chronic selective autophagy
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S1535610823004476
  22. Nov 2023
  23. www.nature.com www.nature.com
    Probabilities of developing HIV-1 bNAb sequence features in uninfected and chronically infected individuals
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    nature.com/articles/s41467-023-42906-y
  24. Jul 2023
  25. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Aged/Autoimmune B-cell Program Defines the Early Transformation of Extranodal Lymphomas
    3
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC9839622/
  26. Apr 2023
  27. aacrjournals.org aacrjournals.org
    IOA-244 is a Non–ATP-competitive, Highly Selective, Tolerable PI3K Delta Inhibitor That Targets Solid Tumors and Breaks Immune Tolerance
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    aacrjournals.org/cancerrescommun/article/3/4/576/725855/IOA-244-is-a-Non-ATP-competitive-Highly-Selective
  28. Dec 2022
  29. 52.53.155.43 52.53.155.43
    cd-22-0561-html.html
    2
    Visit annotations in context

    Tags

    Annotators

    URL

    52.53.155.43/a429cb5e58e03f354312204fbbe86e9227a8ee47/cd-22-0561-html.html
  30. Jul 2021
  31. www.sciencedirect.com www.sciencedirect.com
    ASN007 is a selective ERK1/2 inhibitor with preferential activity against RAS-and RAF-mutant tumors
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2666379121001993